PRESTIGE CONSUMER HEALTHCARE INC. (PBH) ROI
- 2026-06-30: ROI 4.37%.
- 2026-03-31: ROI 6.60%.
- 2021-09-30: ROI 5.82%.
- 2021-03-31: ROI 5.80%.
Complete source-backed roi history.
- Available history
- 2014-03-31 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2026-06-30 | 4.37% |
| 2026-03-31 | 6.60% |
| 2021-09-30 | 5.82% |
| 2021-03-31 | 5.80% |
| 2015-06-30 | 4.03% |
| 2015-03-31 | 3.58% |
| 2014-09-30 | 2.29% |
| 2014-03-31 | 4.85% |
Annual ROI
| Date | ROI |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |